SCHEMBL22546075

SCHEMBL22546075

Cc1cnc(Nc2cnn(C3CCN(C(=O)C4CC4)CC3)c2)nc1-c1ccc(O)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 13/20 0.46
▸ CDK2 P24941 2/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ CDK8 P49336 1/20 0.45
▸ CDK7 P50613 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ MYLK4 Q86YV6 1/20 0.44
▸ STK17A Q9UEE5 1/20 0.44
▸ MELK Q14680 3/20 0.44
▸ CDK4 P11802 2/20 0.44
▸ CDK6 Q00534 2/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ JAK2 O60674 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ CSF1R P07333 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29754173 1.00 IGF1R (0.46) IGF1RCDK2CDK1CDK8CDK7
SCHEMBL22544822 0.93 IGF1R (0.53) IGF1RCDK2CDK1CDK8CDK7
SCHEMBL29754277 0.90 CDK4 (0.49) CDK2MYLK4STK17ACDK4CDK6
SCHEMBL22544592 0.90 CDK4 (0.49) CDK2MYLK4STK17ACDK4CDK6
SCHEMBL22544564 0.89 CDK4 (0.54) CDK2MYLK4STK17AMELKCDK4
SCHEMBL29754222 0.89 CDK4 (0.54) CDK2MYLK4STK17AMELKCDK4
SCHEMBL22544658 0.89 IGF1R (0.44) IGF1RCDK2CDK1CDK8CDK7
SCHEMBL28712152 0.88 MYLK4 (0.45) IGF1RCDK2CDK1CDK8CDK7
SCHEMBL27169598 0.87 LRRK2 (0.48) IGF1RCDK2CDK1CDK8CDK7
SCHEMBL27275338 0.86 IGF1R (0.46) IGF1RCDK2CDK1CDK8CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024503-B2 Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-07-02 — — US disclosed
US-12024503-B2 Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-07-02 — — US disclosed
WO-2020207414-A1 BENZETHERS AND ANILINES OF PYRAZOLYL-AMINO-PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2020-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12024503-B2 Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof JAK3, JAK1, JAK2 IGF1R 3027/4885CDK2 125/4885CDK1 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback